G/TBT/N/PHL/300  
10 February 2023  
(23-0991) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  PHILIPPINES  
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
DR. SAMUEL A. ZACATE  
Director General  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notific ation shall be indicated if different from above:   
MARIA CECILIA C. MATIENZO  
Director IV  
Center for Device Regulation, Radiation Health, and Research  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Email: mccmatienzo@fda.gov.ph  ; cdrrhr@fda.gov.ph  ; bps@dti.gov.ph  
www.fda.gov.ph  
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], 3.2 [  ], 7.2 [  ], 
other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Machinery, 
plant or laboratory equipment whether or not electrically heated (excl. furnaces, ovens 
and other equipment of heading 8514), for the treatment of materials by a process 
involving a change of temperature such as heating, cooking, roasting, distilling, rectifying, 
sterilising, pasteurising, steaming, drying, evaporating, vaporising, condensing or cooling 
(excl. those used for domestic purposes); instantaneous or storage water heaters, non -
electric; parts thereof (HS code(s): 8419)  
5. Title, number of pages and language(s) of the notified document:  "Addendum to 
Administrative Order No. 50 s.2001 entitled "Revised 2001 Schedule of Fees and Charges 
for the Corresponding Services Rendered by the Bureau of Food and Drugs"; (3 page(s), 
in English)  
6. Description of content:  The issuance aims to provide refe rence for the licensing fees of 
manufacturers, traders, and distributors (importers, exporters, and wholesalers) of 
health -related devices such as equipment or devices used for treating sharps, 
pathological, and infectious wastes, and water treatment devic es/systems.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Protection of human health or safety  G/TBT/N/PHL/300  
 
- 2 - 
 
  8. Relevant documents:   
• Republic Act 9711 "Food and Drug Administration (FDA) Act of 2009"  
• Administrative Order (AO) No. 2020 -0017 "Revised Guidelines on the Unified 
Licensing Requirements and Procedures of the Food and Drug Administration 
Repealing Administrative Order No. 2016 -0003"  
• AO No.50 series 2001 "Revised 2001 Schedule of Fees and Charges for the 
Correspond ing Services Rendered by the Bureau of Food and Drugs"  
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  
10. Final date for comments:  60 days from notification  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Mr. Neil P. Catajay  
Director  
Bureau of Philippine Standards  
Department of Trade and Industry  
3F Trade and Industry Building  
361 Sen. Gil Puyat Avenue  
Makati City  
Philippines  
Tel: (632) 751 4700; (632) 7913128  
Email: bps@dti.gov.ph  
Website: http://www.bps.dti.gov.ph  
https://www.fda.gov .ph/draft -for-comments -addendum -to-administrative -order -no-50-
s-2001-entitled -revised -2001-schedule -of-fees-and-charges -for-the-corresponding -
services -rendered -by-the-bureau -of-food-and-drug/  
https://members.wto.org/crnattachments/2023/TBT/PHL/23_1031_00_e.pdf